The Next Generation of Vivace® is Announced, Introducing Vivace Ultra™

The Beginning of a New Era with Unmatched Precision, Vision, and Technology. Phoenix, AZ July 08, 2022 --( )-- Aesthetics Biomedical® is creating an entirely new category that redefines what is possible in personalized medical aesthetics, offering a novel approach to clinical precision and treatment delivery, elevating consumer outcomes and experience. Vivace Ultra™, now awaiting FDA Clearance, provides physicians and aesthetic practitioners unmatched precision, visualization, and the most versatile radiofrequency (RF) microneedling technology available. An innovative reimagination and technical upgrade of the legacy Vivace® Microneedle RF treatment and device, the Vivace Ultra™ combines two unique modalities into one compact device, delivering the most bespoke, personalized treatment experience possible. This new era of advanced energy-based technology offers data-supported treatment parameters made possible by an industry-first ultrasound imaging and mapping, an exclusive uniform radiofrequency microneedling energy delivery system, range of frequency options, and a HIPAA compliant patient data-tracking system for optimal consumer results and treatment plans. Without a doubt, Vivace Ultra™ is the next generation of the Vivace® Microneedle RF. A recent clinical study found that 95% of patients noticed an improvement in skin texture after a series of treatments between 2-6 sessions. 94% of these patients said they would recommend radiofrequency microneedling to a friend1. On the RealSelf platform, the legacy Vivace® Microneedle RF treatment has become the most requested microneedling treatment2. Building upon an already best-in-class device, Vivace Ultra™ has been developed alongside and in collaboration with key opinion leaders. The new device’s technology and user-friendliness is based ... Full story available on